Met-targeted radioligand therapy in KRAS-pathway activated pancreatic cancer resistant to Met kinase inhibitors Meeting Abstract


Authors: Escorcia, F. E.; Houghton, J.; Abdel-Atti, D.; Pereira, P.; Cho, A.; Lewis, J. S.
Abstract Title: Met-targeted radioligand therapy in KRAS-pathway activated pancreatic cancer resistant to Met kinase inhibitors
Meeting Title: 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 105
Issue: 1 Suppl.
Meeting Dates: 2019 Sep 15-18
Meeting Location: Chicago, IL
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2019-09-01
Start Page: E235
Language: English
ACCESSION: WOS:000485671500537
DOI: 10.1016/j.ijrobp.2019.06.2007
PROVIDER: wos
Notes: Meeting Abstract: 2541 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jason S Lewis
    458 Lewis
  2. Andrew Cho
    5 Cho